Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan.
about
Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Safety and Effectiveness of Na ...... rketing Surveillance in Japan.
@en
Safety and Effectiveness of Na ...... rketing Surveillance in Japan.
@nl
type
label
Safety and Effectiveness of Na ...... rketing Surveillance in Japan.
@en
Safety and Effectiveness of Na ...... rketing Surveillance in Japan.
@nl
prefLabel
Safety and Effectiveness of Na ...... rketing Surveillance in Japan.
@en
Safety and Effectiveness of Na ...... rketing Surveillance in Japan.
@nl
P2093
P2860
P1476
Safety and Effectiveness of Na ...... rketing Surveillance in Japan.
@en
P2093
Haruki Makioka
Kazumasa Yokoyama
Masakazu Hase
Ryusuke Sato
Shinichi Torii
Takahiko Saida
Yukihiko Iizuka
P2860
P2888
P304
P356
10.1007/S40120-017-0084-6
P577
2017-11-08T00:00:00Z